Back to results
US 2016/0108456 A1Published application
Method for establishing the anti-diabetic potential of bitter melon
AssigneeGlykon Technologies Group, LLC
InventorsDallas L. CLOUATRE, Daniel E. CLOUATRE
Life of this patent
Estimating the term…
Abstract
A method is disclosed for determining the hypoglycemic potential of Momordica charantia (bitter melon) extracts through an in vitro test representative of the range of serum blood sugar typical of normal and diabetic subjects. The in vitro assay provides information on the functional activity of bitter melon extracts for regulating blood glucose uptake in an animal or human
Claims12
A method for determining in vitro the functional in vivo activity of bitter melon extracts for regulating blood glucose uptake in an animal or human.
-11. (canceled)
Dependencies are inferred from the claim text.